A streptavidin mutant has been designed and produced that allows the specif
ic, covalent immobilization of streptavidin on solid surfaces. This strepta
vidin mutant was constructed by fusing a six-residue sequence, containing a
single cysteine, to the carboxyl terminus of streptavidin. Because this mu
tant has no other cysteine residues, the reactive sulfhydryl group of the c
ysteine residue serves as a unique immobilization site for corrugation usin
g sulfhydryl chemistry. This streptavidin mutant was efficiently immobilize
d on maleimide-coated solid surfaces via, its unique immobilization site. C
haracterization of the immobilized streptavidin mutant for the ability to b
ind to biotinylated macromolecules and the dissociation rates of bound biot
in showed that the biotin-binding properties of this mutant were minimally
affected by immobilization on solid surfaces. This streptavidin could be re
adily incorporated into a wide variety of solid-phase diagnostic tests and
biomedical assays. This could enhance the performance of streptavidin-based
solid-phase assay systems.